Title
Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
Date Issued
21 January 2020
Access level
open access
Resource Type
journal article
Author(s)
Miao B.
Alberts M.J.
Mangiafico N.
Coleman C.I.
University of Connecticut School of Pharmacy
Hartford Hospital Evidence-Based Practice Center
Publisher(s)
American Heart Association Inc.
Abstract
Background: There is a paucity of contemporary data estimating the incidence of major adverse cardiovascular events (MACE) in patients with established atherosclerotic disease or multiple risk factors managed in routine practice. We estimated 1- and 4-year incidences of MACE and the association between MACE and vascular beds affected in these patients. Methods and Results: Using US IBM MarketScan data from January 1, 2013 to December 31, 2017, we identified patients ≥45 years old with established coronary artery disease, cerebrovascular disease, peripheral artery disease, or the presence of ≥3 risk factors for atherosclerosis during 2013 with a minimum of 4 years of follow-up. We calculated 1- and 4-year incidences of MACE (cardiovascular death or hospitalization for myocardial infarction or ischemic stroke). A Cox proportional hazards regression model adjusted for age and sex was used to evaluate the association between vascular bed number/location(s) affected and MACE. We identified 1 302 856 patients with established atherosclerotic disease or risk factors for atherosclerosis. Coronary artery disease was present in 16.9% of patients, cerebrovascular disease in 7.6%, peripheral artery disease in 13.6%, and risk factors for atherosclerosis only in 66.0%. The 1- and 4-year incidences of MACE were 1.4% and 6.9%, respectively. At 4 years, MACE was more frequent in patients with atherosclerotic disease in a single (hazard ratio=1.51, 95% CI=1.48–1.55), 2-(hazard ratio=2.35, 95% CI=2.27–2.44), or all 3 vascular beds (hazard ratio=3.30, 95% CI=2.97–3.68) compared with having risk factors for atherosclerosis. Conclusions: Patients with established atherosclerotic disease or who have multiple risk factors and are treated in contemporary, routine practice carry a substantial risk for MACE at 1- and 4- years of follow-up. MACE risk was shown to vary based on the number and location of vascular beds involved.
Volume
9
Issue
2
Language
English
OCDE Knowledge area
Sistema cardiaco, Sistema cardiovascular
Scopus EID
2-s2.0-85077897197
PubMed ID
Source
Journal of the American Heart Association
Sponsor(s)
Coleman has received research funding and honoraria from Bayer AG (significant), Janssen Scientific Affairs LLC (significant), and Portola Pharmaceuticals, Inc (modest). Alberts reports consultancy or speaker fees and honoraria from Genentech (modest), Janssen Pharmaceuticals (significant), Boehringer Ingelheim (modest), Pfizer (significant), Bristol-Myers Squibb (significant), Medscape (modest), Portola (significant), and patents/royalties from Duke University (modest). The remaining authors have no disclosures to report. Funding was provided by Bayer AG, Berlin, Germany and a Medical Staff Internal Grant from Hartford Hospital, Hartford, CT. MarketScan data used in this study were obtained from IBM under a third-party license agreement with Bayer AG, Berlin, Germany. Funding was provided by Bayer AG, Berlin, Germany and a Medical Staff Internal Grant from Hartford Hospital, Hartford, CT. MarketScan data used in this study were obtained from IBM under a third‐party license agreement with Bayer AG, Berlin, Germany. The funders of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors have approved the final manuscript.
Sources of information: Directorio de Producción Científica Scopus